119-4, enacted March 15, 2025) through September 30, 2025 (that is, for services furnished no later than September 30, 2025)
Visceral and liver fat reductions are material over time, alongside improving lipid panels and insulin
Good candidates for this treatment include any adult who would like to increase their metabolism and burn fat more quickly
It can cause the peptide molecules to break apart, a process called denaturation
Read Announcement View Product Photos Summary Company Announcement Date: FDA Publish Date: Product Type: Drugs Reason for Announcement: Recall Reason DescriptionProducts are out of specification Company Name: Olympia Pharmacy Brand Name: Brand Name(s)Olympia Pharmaceuticals Product Description: Product DescriptionCompounded Injectables Company Announcement Olympia Pharmacy is voluntarily recalling 11 specific lots of Trimix Formulas F-9, T-105, SB-4, Sermorelin, Sincalide, Hydroxocobalamin, and NAD, compounded injectables to the consumer level
